| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-11-06 | 2009-09-30 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 56,640 | Sold Some | -1,555 | -2.67 % | $1,954,080 | $2,072,458 | $118,378 | 6.05 % | $-3,250 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2009-08-05 | 2009-06-30 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 58,195 | Sold Some | -740 | -1.25 % | $2,019,367 | $2,129,355 | $109,989 | 5.44 % | $-1,399 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2009-05-05 | 2009-03-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 58,935 | Added More | 715 | 1.22 % | $2,035,615 | $2,156,432 | $120,817 | 5.93 % | $1,466 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2009-01-27 | 2008-12-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 58,220 | Added More | 85 | 0.14 % | $2,247,874 | $2,130,270 | $-117,604 | -5.23 % | $-172 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2008-11-05 | 2008-09-30 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 58,135 | Sold Some | -400 | -0.68 % | $1,962,638 | $2,127,160 | $164,522 | 8.38 % | $-1,132 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2008-07-18 | 2008-06-30 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 58,535 | Sold Some | -3,200 | -5.18 % | $2,804,412 | $2,141,796 | $-662,616 | -23.62 % | $36,224 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2008-05-01 | 2008-03-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 61,735 | Added More | 3,150 | 5.37 % | $3,069,464 | $2,258,884 | $-810,581 | -26.40 % | $-41,360 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2008-02-08 | 2007-12-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 58,585 | Sold Some | -525 | -0.88 % | $2,942,725 | $2,143,625 | $-799,099 | -27.15 % | $7,161 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2007-11-05 | 2007-09-30 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 59,110 | Sold Some | -3,600 | -5.74 % | $3,083,178 | $2,162,835 | $-920,343 | -29.85 % | $56,052 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2007-07-25 | 2007-06-30 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 62,710 | Sold Some | -1,455 | -2.26 % | $3,664,772 | $2,294,559 | $-1,370,214 | -37.38 % | $31,792 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2007-04-19 | 2007-03-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 64,165 | Sold Some | -1,850 | -2.80 % | $3,851,183 | $2,347,797 | $-1,503,386 | -39.03 % | $43,346 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2007-03-19 | 2006-12-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 66,015 | Sold Some | -5,955 | -8.27 % | $3,477,670 | $2,415,489 | $-1,062,181 | -30.54 % | $95,816 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2006-12-14 | 2006-09-30 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 71,970 | Sold Some | -1,500 | -2.04 % | $3,884,221 | $2,633,382 | $-1,250,839 | -32.20 % | $26,070 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2006-07-13 | 2006-03-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 73,470 | Added More | 27,070 | 58.34 % | $4,032,034 | $2,688,267 | $-1,343,766 | -33.32 % | $-495,110 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2006-01-05 | 2005-12-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 46,400 | Sold Some | -3,156 | -6.36 % | $2,662,896 | $1,697,776 | $-965,120 | -36.24 % | $65,645 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2005-10-03 | 2005-09-30 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 49,556 | Added More | 2,451 | 5.20 % | $2,622,999 | $1,813,254 | $-809,745 | -30.87 % | $-40,049 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2005-07-14 | 2005-06-30 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 47,105 | Added More | 825 | 1.78 % | $2,682,159 | $1,723,572 | $-958,587 | -35.73 % | $-16,789 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2005-04-27 | 2005-03-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 46,280 | Added More | 8,750 | 23.31 % | $2,694,884 | $1,693,385 | $-1,001,499 | -37.16 % | $-189,350 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2004-06-04 | 2004-03-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 37,530 | Added More | 2,050 | 5.77 % | $2,814,750 | $1,373,223 | $-1,441,527 | -51.21 % | $-78,741 | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
| 2004-02-24 | 2003-12-31 | 13F-HR | Eli Lilly And Co | LLY | US | Medical-Drugs | 35,480 | No Compare | - | - % | $2,567,688 | $1,298,213 | $-1,269,474 | -49.44 % | | | | | | | History of Chelsea Counsel Co Ownership Of Eli Lilly And Co |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |